Impairment of colorectal cancer screening during the COVID-19 pandemic
- PMID: 34015353
- PMCID: PMC9259281
- DOI: 10.1016/S2468-1253(21)00136-9
Impairment of colorectal cancer screening during the COVID-19 pandemic
Conflict of interest statement
We declare no competing interests. SS and MSI contributed equally to this Correspondence.
Comment on
-
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3. Lancet Gastroenterol Hepatol. 2021. PMID: 33548185 Free PMC article.
-
Impairment of colorectal cancer screening during the COVID-19 pandemic.Lancet Gastroenterol Hepatol. 2021 Jun;6(6):425-426. doi: 10.1016/S2468-1253(21)00098-4. Lancet Gastroenterol Hepatol. 2021. PMID: 34015352 Free PMC article. No abstract available.
References
-
- Spada C, Hassan C, Bellini D, et al. Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline—update 2020. Eur Radiol. 2020;52:1127–1141. - PubMed
-
- Holleran G, Leen R, O'Morain C, McNamara D. Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology. Endoscopy. 2014;46:473–478. - PubMed
-
- Chetcuti Zammit S, Sidhu R. Capsule endoscopy—recent developments and future directions. Expert Rev Gastroenterol Hepatol. 2021;15:127–137. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
